<?xml version="1.0" encoding="UTF-8"?>
<p>Microbial species were selected according to a Pharmacopoeia Article (5.1.4., Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use—“Special Ph. Eur. Provision for oral dosage forms containing raw materials of natural (animal, vegetal or mineral) origin for which antimicrobial pretreatment is not feasible and for which the competent authority accepts TAMC (total aerobic microbial count) of the raw material exceeding 10
 <sup>3</sup> CFU/g or CFU/mL”) and the swab samples were taken from the equipment and containers. All tests of microbial growth were performed according to European Pharmacopoeia methods [
 <xref rid="B37-pharmaceutics-13-00238" ref-type="bibr">37</xref>,
 <xref rid="B38-pharmaceutics-13-00238" ref-type="bibr">38</xref>].
</p>
